Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

PLLA injections can cause hair loss and skin issues.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Ocrelizumab may cause pancreatitis in some patients.

Poly-L-lactic acid injections can cause hair loss and skin issues.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

PRP is a promising non-surgical option for skin and hair rejuvenation.

A patient's grey hair regained color during treatment with adalimumab.

PRP is effective for treating patchy alopecia areata.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Abrocitinib may effectively treat Lichen Planopilaris.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

PDRN is effective and safe for healing wounds and skin issues.

Apremilast may help treat hair loss in alopecia areata.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Most patients use PRP for hair loss and facial rejuvenation with minor side effects.

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.